Description
Composition- Teneligliptin 20 mg
Mode of Action- DPP-4 inhibitor that enhances incretin activity, improving glucose-dependent insulin secretion and reducing glucagon release.
USPs- Effective oral antidiabetic therapy; low hypoglycemia risk; useful in type 2 diabetes management.
Prescribing Specialties- Diabetologist, General Physician, Internal Medicine
